There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains

Maria C. Bell, Delf Schmidt-Grimminger, Sarah Patrick, Tim Ryschon, Laurie Linz, Subhash Chauhan

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objectives: Cervical cancer is the leading gynecological malignancy worldwide, and the incidence of this disease is very high in American Indian women. Infection with the human papillomavirus (HPV) is responsible for more than 95% of cervical squamous carcinomas. Therefore, the main objective of this study was to analyze oncogenic HPV infections in American Indian women residing in the Northern Plains. Methods: Cervical samples were collected from 287 women attending a Northern Plains American Indian reservation outpatient clinic. DNA was extracted from the cervical samples and HPV-specific DNA was amplified by polymerase chain reaction (PCR) using the L1 consensus primer sets. The PCR products were hybridized with the Roche HPV Line Blot assay for HPV genotyping to detect 27 different low- and high-risk HPV genotypes. The Chi-squared test was performed for statistical analysis of the HPV infection and cytology diagnosis data. Results: Of the total 287 patients, 61 women (21.25%) tested positive for HPV infection. Among all HPV-positive women, 41 (67.2%) were infected with high-risk HPV types. Of the HPV infected women, 41% presented with multiple HPV genotypes. Additionally, of the women infected with oncogenic HPV types, 20 (48.7%) were infected with HPV16 and 18 and the remaining 21 (51.3%) were infected with other oncogenic types (i.e., HPV59, 39, 73). Women infected with oncogenic HPV types had significantly higher (p = 0.001) abnormal Papanicolaou smear tests (Pap test) compared to women who were either HPV negative or positive for non-oncogenic HPV types. The incidence of HPV infection was inversely correlated (p < 0.05) with the age of the patients, but there was no correlation (p = 0.33) with seasonal variation. Conclusions: In this study, we observed a high prevalence of HPV infection in American Indian women residing on Northern Plains Reservations. In addition, a significant proportion of the oncogenic HPV infections were other than HPV16 and 18.

Original languageEnglish (US)
Pages (from-to)236-241
Number of pages6
JournalGynecologic oncology
Volume107
Issue number2
DOIs
StatePublished - Nov 1 2007
Externally publishedYes

Fingerprint

Papillomavirus Infections
North American Indians
Papanicolaou Test
Genotype
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains. / Bell, Maria C.; Schmidt-Grimminger, Delf; Patrick, Sarah; Ryschon, Tim; Linz, Laurie; Chauhan, Subhash.

In: Gynecologic oncology, Vol. 107, No. 2, 01.11.2007, p. 236-241.

Research output: Contribution to journalArticle

Bell, Maria C. ; Schmidt-Grimminger, Delf ; Patrick, Sarah ; Ryschon, Tim ; Linz, Laurie ; Chauhan, Subhash. / There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains. In: Gynecologic oncology. 2007 ; Vol. 107, No. 2. pp. 236-241.
@article{d09db4e1069e46e28d32944918dcf7a7,
title = "There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains",
abstract = "Objectives: Cervical cancer is the leading gynecological malignancy worldwide, and the incidence of this disease is very high in American Indian women. Infection with the human papillomavirus (HPV) is responsible for more than 95{\%} of cervical squamous carcinomas. Therefore, the main objective of this study was to analyze oncogenic HPV infections in American Indian women residing in the Northern Plains. Methods: Cervical samples were collected from 287 women attending a Northern Plains American Indian reservation outpatient clinic. DNA was extracted from the cervical samples and HPV-specific DNA was amplified by polymerase chain reaction (PCR) using the L1 consensus primer sets. The PCR products were hybridized with the Roche HPV Line Blot assay for HPV genotyping to detect 27 different low- and high-risk HPV genotypes. The Chi-squared test was performed for statistical analysis of the HPV infection and cytology diagnosis data. Results: Of the total 287 patients, 61 women (21.25{\%}) tested positive for HPV infection. Among all HPV-positive women, 41 (67.2{\%}) were infected with high-risk HPV types. Of the HPV infected women, 41{\%} presented with multiple HPV genotypes. Additionally, of the women infected with oncogenic HPV types, 20 (48.7{\%}) were infected with HPV16 and 18 and the remaining 21 (51.3{\%}) were infected with other oncogenic types (i.e., HPV59, 39, 73). Women infected with oncogenic HPV types had significantly higher (p = 0.001) abnormal Papanicolaou smear tests (Pap test) compared to women who were either HPV negative or positive for non-oncogenic HPV types. The incidence of HPV infection was inversely correlated (p < 0.05) with the age of the patients, but there was no correlation (p = 0.33) with seasonal variation. Conclusions: In this study, we observed a high prevalence of HPV infection in American Indian women residing on Northern Plains Reservations. In addition, a significant proportion of the oncogenic HPV infections were other than HPV16 and 18.",
author = "Bell, {Maria C.} and Delf Schmidt-Grimminger and Sarah Patrick and Tim Ryschon and Laurie Linz and Subhash Chauhan",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.ygyno.2007.06.007",
language = "English (US)",
volume = "107",
pages = "236--241",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains

AU - Bell, Maria C.

AU - Schmidt-Grimminger, Delf

AU - Patrick, Sarah

AU - Ryschon, Tim

AU - Linz, Laurie

AU - Chauhan, Subhash

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Objectives: Cervical cancer is the leading gynecological malignancy worldwide, and the incidence of this disease is very high in American Indian women. Infection with the human papillomavirus (HPV) is responsible for more than 95% of cervical squamous carcinomas. Therefore, the main objective of this study was to analyze oncogenic HPV infections in American Indian women residing in the Northern Plains. Methods: Cervical samples were collected from 287 women attending a Northern Plains American Indian reservation outpatient clinic. DNA was extracted from the cervical samples and HPV-specific DNA was amplified by polymerase chain reaction (PCR) using the L1 consensus primer sets. The PCR products were hybridized with the Roche HPV Line Blot assay for HPV genotyping to detect 27 different low- and high-risk HPV genotypes. The Chi-squared test was performed for statistical analysis of the HPV infection and cytology diagnosis data. Results: Of the total 287 patients, 61 women (21.25%) tested positive for HPV infection. Among all HPV-positive women, 41 (67.2%) were infected with high-risk HPV types. Of the HPV infected women, 41% presented with multiple HPV genotypes. Additionally, of the women infected with oncogenic HPV types, 20 (48.7%) were infected with HPV16 and 18 and the remaining 21 (51.3%) were infected with other oncogenic types (i.e., HPV59, 39, 73). Women infected with oncogenic HPV types had significantly higher (p = 0.001) abnormal Papanicolaou smear tests (Pap test) compared to women who were either HPV negative or positive for non-oncogenic HPV types. The incidence of HPV infection was inversely correlated (p < 0.05) with the age of the patients, but there was no correlation (p = 0.33) with seasonal variation. Conclusions: In this study, we observed a high prevalence of HPV infection in American Indian women residing on Northern Plains Reservations. In addition, a significant proportion of the oncogenic HPV infections were other than HPV16 and 18.

AB - Objectives: Cervical cancer is the leading gynecological malignancy worldwide, and the incidence of this disease is very high in American Indian women. Infection with the human papillomavirus (HPV) is responsible for more than 95% of cervical squamous carcinomas. Therefore, the main objective of this study was to analyze oncogenic HPV infections in American Indian women residing in the Northern Plains. Methods: Cervical samples were collected from 287 women attending a Northern Plains American Indian reservation outpatient clinic. DNA was extracted from the cervical samples and HPV-specific DNA was amplified by polymerase chain reaction (PCR) using the L1 consensus primer sets. The PCR products were hybridized with the Roche HPV Line Blot assay for HPV genotyping to detect 27 different low- and high-risk HPV genotypes. The Chi-squared test was performed for statistical analysis of the HPV infection and cytology diagnosis data. Results: Of the total 287 patients, 61 women (21.25%) tested positive for HPV infection. Among all HPV-positive women, 41 (67.2%) were infected with high-risk HPV types. Of the HPV infected women, 41% presented with multiple HPV genotypes. Additionally, of the women infected with oncogenic HPV types, 20 (48.7%) were infected with HPV16 and 18 and the remaining 21 (51.3%) were infected with other oncogenic types (i.e., HPV59, 39, 73). Women infected with oncogenic HPV types had significantly higher (p = 0.001) abnormal Papanicolaou smear tests (Pap test) compared to women who were either HPV negative or positive for non-oncogenic HPV types. The incidence of HPV infection was inversely correlated (p < 0.05) with the age of the patients, but there was no correlation (p = 0.33) with seasonal variation. Conclusions: In this study, we observed a high prevalence of HPV infection in American Indian women residing on Northern Plains Reservations. In addition, a significant proportion of the oncogenic HPV infections were other than HPV16 and 18.

UR - http://www.scopus.com/inward/record.url?scp=35348869452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348869452&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2007.06.007

DO - 10.1016/j.ygyno.2007.06.007

M3 - Article

VL - 107

SP - 236

EP - 241

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -